Example: Heart Attack

Clinical Trials on Leishmaniasis, Mucocutaneous

Total 10 results

    • NCT00111514
      Completed
      Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Mucosal Leishmaniasis
      Conditions: Leishmaniasis, Mucocutaneous
    • NCT01377974
      Completed
      Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis
      Conditions: Leishmaniasis; Leishmaniasis, Mucocutaneous
    • NCT02429518
      Completed
      Dedicated QT Study in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis
      Conditions: Mucocutaneous Leishmaniasis
    • NCT02431429
      Completed
      Spermiogram Assessment in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis
      Conditions: Mucocutaneous Leishmaniasis
    • NCT01301937
      Recruiting
      Low Antimonial Dosage in American Mucosal Leishmaniasis
      Conditions: Mucosal Leishmaniasis; Mucocutaneous Leishmaniasis
    • NCT01050907
      Completed
      Miltefosine to Treat Mucocutaneous Leishmaniasis
      Conditions: Mucosal Leishmaniasis; Cutaneous Leishmaniasis
    • NCT00508963
      Available
      Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis
      Conditions: Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous
    • NCT02530697
      Recruiting
      The Association of Miltefosine and Pentoxifylline to Treat Mucosal Leishmaniasis: A Clinical Trial in Brazil
      Conditions: Leishmaniasis
    • NCT00373776
      Completed
      Miltefosine for Mucosal Leishmaniasis
      Conditions: Leishmaniasis
    • NCT00373568
      Completed
      Miltefosine (Long Course) for Bolivian Mucosal Leishmaniasis
      Conditions: Leishmaniasis
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations